the present invention relates to a pharmaceutical composition containing a dopamine agonist or a pharmaceutically acceptable salt thereof , a compound of the formula i as defined in the specification , and optionally a pharmaceutically acceptable carrier , and to their medicinal use . these compositions are useful as psychotherapeutic agents .